ERcast: Clinical Perspectives Podcast Preview
The summary below is from an episode of ERcast: Clinical Perspectives
Massive acetaminophen overdose can outstrip standard N-acetylcysteine therapy and progress to hyperacute liver failure within 72 to 96 hours. Risk stratification hinges on ingestion size, timed acetaminophen levels, and early recognition of delayed absorption from opioid or anticholinergic co-ingestion.
High-Risk Acetaminophen Ingestion
- Massive ingestion framing: Acetaminophen toxicity becomes a different problem when NAPQI generation overwhelms glutathione stores, making standard NAC potentially insufficient in very large overdoses.
- High-risk ingestion markers: High-risk cases are flagged by a reported ingestion over 30 g or a timed acetaminophen level that remains markedly elevated at 4 or 8 hours after exposure.
- Escalated NAC strategy: For high-risk ingestions, consensus guidance increases the third IV NAC dose to 200 mg/kg over 16 hours rather than the usual maintenance dose. We get into when to make that jump in the episode.
- Fomepizole adjunct role: Fomepizole is considered a reasonable adjunct in selected massive ingestions because CYP2E1 inhibition may reduce further NAPQI formation despite limited human outcome data.
- Early toxicology involvement: Poison Control and an on-call toxicologist should be involved early for high-risk cases, especially when labs worsen despite treatment or fulminant hepatic failure is emerging.
Dialysis, Transfer, and Delayed Absorption
- Extracorporeal treatment threshold: EXTRIP guidance supports hemodialysis or CRRT when the acetaminophen concentration exceeds 900 mcg/mL, a range where antidote therapy alone may not be enough.
- Transfer center triggers: Coagulopathy, severe transaminase elevation, metabolic acidosis, renal injury, or cerebral edema should push early transfer to a tertiary or transplant-capable center.
- Hyperacute liver failure window: The sickest patients can declare themselves quickly, with hyperacute liver failure appearing within 72 to 96 hours of ingestion rather than over a prolonged timeline.
- Line jumper phenomenon: Some patients cross the treatment line late because opioid or anticholinergic co-ingestion delays gastric emptying and shifts the acetaminophen peak to 8 hours.
- Co-ingestion bedside clues: Mydriasis, urinary retention, and decreased bowel sounds suggest anticholinergic delay, while miosis, bradypnea, and lethargy point toward an opioid co-ingestant. We walk through how that changes the timing strategy in the chapter.
Subscribe to ERcast: Clinical Perspectives to listen to the episode.
References:
- Dart RC et al. Management of Acetaminophen Poisoning in the US and Canada: A Consensus Statement. JAMA Netw Open. 2023 Aug 1;6(8):e2327739. Erratum in: JAMA Netw Open. 2023 Sep 5;6(9):e2337926. PMID: 37552484.
- Chiew AL, Isbister GK, Kirby KA, Page CB, Chan BSH, Buckley NA. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol (Phila). 2017;55(10):1055-1065. PMID: 28644687
- Akakpo JY, Ramachandran A, Duan L, et al. Delayed Treatment With 4-Methylpyrazole Protects Against Acetaminophen Hepatotoxicity in Mice by Inhibition of c-Jun n-Terminal Kinase. Toxicol Sci. 2019;170(1):57-68. PMID: 30903181
- Gosselin S, Juurlink DN, Kielstein JT, et al. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014;52(8):856-867. PMID: 25133498
Faculty
- Matthew DeLaney, MD, FACEP, FAAEM
Dr. Matthew DeLaney is an emergency medicine physician and educator based in Birmingham, Alabama. A native of Mobile, he earned his medical degree from the University of South Alabama and completed his emergency medicine residency at Maine Medical Center.Dr. DeLaney has experience in both community and academic emergency medicine and is known for his commitment to teaching and medical education. He lives in Birmingham with his wife, Erin, who is also a physician, and their two daughters.
- Will Rushton, MD